Pan-Cancer Analysis Reveals the Potential of PLOD1 as a Prognostic and Immune Biomarker for Human Cancer
<b>Background/Objectives:</b> Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 (PLOD1) is known as an enhancer of collagen fiber deposition and cross-linking stability. However, there is limited information on its function in tumors. In this study, we aimed to elucidate the function an...
Saved in:
Main Authors: | Zhao Zhai, Shuo Wang, Yudong Cao, Jia Liu, Qiang Zhao, Yongpeng Ji, Xiao Yang, Xingxing Tang, Jinchao Ma, Peng Du |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/12/12/2653 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pan-immune-inflammation value as a novel prognostic biomarker for digestive system cancers: a meta-analysis
by: Dongli Yu, et al.
Published: (2024-11-01) -
Comprehensive pan-cancer analysis reveals NTN1 as an immune infiltrate risk factor and its potential prognostic value in SKCM
by: Fuxiang Luan, et al.
Published: (2025-01-01) -
Pan-cancer analysis shows that BCAP31 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types
by: Yangyong Sun, et al.
Published: (2024-12-01) -
Pan-cancer analysis shows that TNFSF4 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including liver cancer
by: Zhaoda Deng, et al.
Published: (2025-01-01) -
Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types
by: Peiyi Xu, et al.
Published: (2024-12-01)